# Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics

> **NCT03466502** · PHASE4 · COMPLETED · sponsor: **University of Nevada, Reno** · enrollment: 104 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DRUG:** Oral Vancomycin

## Key facts

- **NCT ID:** NCT03466502
- **Lead sponsor:** University of Nevada, Reno
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-08
- **Primary completion:** 2022-02-17
- **Final completion:** 2022-02-17
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2023-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03466502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03466502, "Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03466502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*